India launched the world’s first intranasal COVID-19 vaccine
iNCOVACC, a product of Bharat Biotech, is delivered as drops and triggers an immune response in the tissues lining the nasal canal. It is based on technology licensed from Washington University School of Medicine in St. Louis, in the U.S. Bharat Biotech International Limited (BBIL) is one of the leading innovation and developer of vaccine […]
India launched the world’s first intranasal COVID-19 vaccine Read More »